Comparison
Abacavir Hypersensitivity C5768819 vs 3 5 Finger Cutaneous Syndactyly C5937270
Clinical comparison between Abacavir Hypersensitivity and 3 5 Finger Cutaneous Syndactyly for differential diagnosis and treatment planning.
Abacavir Hypersensitivity C5768819
A potentially serious immune reaction to the HIV drug abacavir. Genetic testing is required before starting treatment to identify those at risk of this reaction.
3 5 Finger Cutaneous Syndactyly C5937270
Skin connection between the third and fifth fingers from birth. May affect hand function or appearance. Surgery to separate fingers may be an option.
6 comparison axes
Onset
Abacavir Hypersensitivity C5768819
Variable
3 5 Finger Cutaneous Syndactyly C5937270
0-0
Onset patterns differ
Severity
Abacavir Hypersensitivity C5768819
severe
3 5 Finger Cutaneous Syndactyly C5937270
mild
Different severity levels
Chronic
Abacavir Hypersensitivity C5768819
Acute
3 5 Finger Cutaneous Syndactyly C5937270
Chronic
Differing course
Communicable
Abacavir Hypersensitivity C5768819
No
3 5 Finger Cutaneous Syndactyly C5937270
No
Different transmission
Body System
Abacavir Hypersensitivity C5768819
immunologic
3 5 Finger Cutaneous Syndactyly C5937270
musculoskeletal
Same/different system
Category
Abacavir Hypersensitivity C5768819
immunologic
3 5 Finger Cutaneous Syndactyly C5937270
genetic
Different category
Bottom line
abacavir-hypersensitivity-C5768819 and 3-5-finger-cutaneous-syndactyly-C5937270 differ in severity, chronicity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abacavir Hypersensitivity C5768819 | 3 5 Finger Cutaneous Syndactyly C5937270 | Discriminating power |
|---|---|---|---|
| Timing | Usually appears after abacavir exposure; timing varies. | Present from birth. | High |
| Affected system | Immune reaction that may involve multiple symptoms. | Localized hand skin webbing. | High |
| Course | Acute and potentially serious if exposure continues. | Chronic congenital finding, generally mild. | High |
When to favor each condition
Choose Abacavir Hypersensitivity C5768819 when
New symptoms after starting abacavir
A drug-related immune reaction should be considered and urgently assessed.
High
Known HLA-B*5701 risk status
Genetic risk testing is used before abacavir; interpretation belongs to the clinician.
Moderate
Symptoms improve after stopping the drug
This pattern may support a drug reaction but is not definitive alone.
Moderate
Choose 3 5 Finger Cutaneous Syndactyly C5937270 when
Webbed skin between fingers 3 and 5 at birth
The finding is congenital and musculoskeletal rather than drug-related.
High
Stable hand appearance without systemic illness
A localized chronic anomaly is more consistent than an acute reaction.
High
Concern about function or appearance
Hand assessment can guide whether separation surgery is appropriate.
Moderate
How key tests differ
| Test | Abacavir Hypersensitivity C5768819 | 3 5 Finger Cutaneous Syndactyly C5937270 | Interpretation |
|---|---|---|---|
| HLA-B*5701 testing | Used before abacavir to identify increased risk. | Not relevant to finger syndactyly. | A risk marker is not itself a diagnosis of hypersensitivity. |
| Clinical examination | Looks for a multisystem drug reaction. | Confirms skin webbing and hand function. | Examination distinguishes an acute reaction from a congenital anomaly. |
| Hand imaging | Not routinely diagnostic. | May clarify bone and soft-tissue anatomy if surgery is considered. | Imaging supports surgical planning; it does not diagnose drug hypersensitivity. |
Prognosis comparison
Abacavir Hypersensitivity C5768819
- Outcome
- Often improves after prompt drug withdrawal, but severe reactions can occur.
- Factors
- Prompt recognition, permanent avoidance, and clinician-directed HIV treatment changes.
3 5 Finger Cutaneous Syndactyly C5937270
- Outcome
- Generally stable; function and appearance depend on anatomy and any surgery.
- Factors
- Extent of webbing, hand function, growth, and surgical outcome if performed.
Time frame: Hours to days for the drug reaction; lifelong for the congenital finding.
These outcomes are general; individual prognosis requires clinical assessment.
Complications comparison
| Complication | Presentation |
|---|---|
| Progression | Can become severe, especially with continued exposure. Usually remains a stable mild anomaly. Exact complication rates are not established here. |
| Function | Systemic symptoms may limit activity during an episode. Hand use or appearance may be affected. Impact varies and needs individual assessment. |
| Treatment-related issues | The implicated drug must be avoided after a suspected reaction. Surgery, if chosen, has procedure-specific risks. Decisions require clinician guidance; doses are not specified. |
Patient education highlights
- HighUrgent drug symptoms
Seek urgent care for suspected abacavir hypersensitivity and do not restart it unless a clinician directs.
- MediumDifferent conditions
A congenital finger connection is not an immune drug reaction and is not contagious.
- MediumHand care decisions
Ask a hand specialist whether observation or surgery best fits function and appearance.